RESUMEN
Co-amorphous strategy has been extensively investigated to improve the dissolution of hydrophobic drugs. Here, epigallocatechin-3-gallate (EGCG) was exploited as a co-former in co-amorphous systems based on its unique structure including phenyl rings, phenolic hydroxyl groups and the galloyl moiety. Two model BCS class II drugs, simvastatin (SIM) and nifedipine (NIF), were selected to be co-amorphized with EGCG. All drug-EGCG systems at three molar ratios became amorphous by the means of spray drying and showed high physically stable either under dry condition and 75 % RH at 40 °C or under dry conditions at 25 °C. The optimal feed molar ratios of both EGCG based co-amorphous systems fabricated were determined to be three, under which the significant increases were obtained in the maximum apparent concentrations of 4.90-fold for SIM at 1 h and 106.03-fold for NIF at 0.25 h compared to crystalline drugs by non-sink dissolution studies. The underlying molecular mechanisms of two co-amorphous systems formation were involved in molecular miscibility, hydrogen bonds and π-π stacking interactions unraveled by means of DSC, FTIR and molecular dynamics simulations. More to the point, oral pharmacokinetic studies in rats demonstrated that co-amorphous SIM-EGCG and NIF-EGCG systems at 1:3 have a significant increase in Cmax of 1.81- and 5.69-fold, and AUC 0-24h of 1.62- and 4.57-fold compared with those of corresponding crystalline drugs, respectively. In conclusion, EGCG is proved to be a promising co-former in co-amorphous systems.
Asunto(s)
Nifedipino , Simvastatina , Animales , Disponibilidad Biológica , Rastreo Diferencial de Calorimetría , Catequina/análogos & derivados , Estabilidad de Medicamentos , Nifedipino/química , Ratas , Simvastatina/química , Solubilidad , Espectroscopía Infrarroja por Transformada de Fourier , Difracción de Rayos XRESUMEN
Natural aglycones, a major ingredient accompanied by glycosides in plants, have played an important role in the treatment of various diseases. However, their bioavailability is limited by their poor water solubility. In contrast to previous efforts that required the use of new exotic materials which may raise concerns about biocompatibility, we report the first case of excipient-free nanodispersions in which an insoluble glycyrrhetinic acid (GA) assembled with its amphiphilic parent drug diammonium glycyrrhizinate (DG) into water-dispersible nanodispersions (130.8 nm for particle size and 91.74% for encapsulation efficiency). This strategy largely increased GA's water apparent solubility by hundreds of times to 549.0 µg/mL with a high cumulative dissolution percentage in vitro greater than 80% in 5 min. The study on the formation mechanism showed that the OH, C-O and C=O group stretching peaks shifted in the FTIR spectra of GA-DG nanodispersions, while the COOH peak (δ COOH 12.19 ppm) disappeared in the 1H NMR spectrum of GA-DG nanodispersions, indicating that carboxyl groups on GA may interact with the hydroxyl groups of DG in solution. Molecular dynamics simulations suggested that both hydrophobic interactions and hydrogen-bond interactions contribute to the coassembly of GA and DG molecules in aqueous solution. Oral pharmacokinetic studies in rats demonstrated that such nanodispersions have a significant increase in Cmax and AUC0-t of 2.45- and 3.45-fold compared with those for GA, respectively. Therefore, this strategy, employing amphiphilic glycosides as excipients to prepare nanodispersions, not using new materials, paves the way for the further application of hydrophobic aglycone drugs.
Asunto(s)
Excipientes , Ácido Glicirretínico , Animales , Disponibilidad Biológica , Excipientes/química , Glicósidos , Ácido Glicirrínico , Interacciones Hidrofóbicas e Hidrofílicas , Ratas , AguaRESUMEN
Nanocrystals, due to high drug loading efficiency, have drawn large attention as nanotechnology to enhance solubility and bioavailability of poorly soluble drugs. However, most nanocrystals still encountered low oral absorption percentage due to its insufficient retention time in the gastrointestinal tract (GI). In this work, silybin (SB) as model drug was fabricated to nanocrystals, and further loaded into a mucoadhesive microsphere to increase the GI retention. Such mucoadhesive microspheres were prepared with a wet media milling technique followed by coagulation and film coating. Nanocrystals and microspheres were thoroughly characterized by diverse complementary techniques. As results, such delivery system displayed an encapsulation efï¬ciency of approximately 100 % and a drug loading capacity of up to 35.41 ± 0.31 %. In addition, mucoadhesiveness test ex vivo conducted with rat intestine showed that ï¬lm-coated microspheres were retained for more than 1 h. Benefiting from nanocrystals technology, the drug cumulative release percentage of the microspheres was remarkable improved compared to unprocessed one in vitro. Finally, pharmacokinetics studies in rats showed a significant 3-fold increase of drug oral bioavailability compared to unprocessed SB. The current study demonstrates that the developed delivery vehicle can enhance the bioavailability of SB by increasing its dissolution percentage as well as through extending retention time in the GI tract, and achieve high drug loading capacity.
Asunto(s)
Nanopartículas , Preparaciones Farmacéuticas , Administración Oral , Animales , Disponibilidad Biológica , Sistemas de Liberación de Medicamentos , Microesferas , Tamaño de la Partícula , Ratas , Silibina , SolubilidadRESUMEN
Radix scutellariae is a well-known traditional Chinese medicine used for the treatments of inflammation, pyrexia, hepatitis, etc. Flavonoids are its main active compounds. The aim of this study is to develop and validate the ultra high-performance liquid chromatography (UHPLC) method for simultaneous determination of 10 flavonoids (baicalin, wogonoside, baicalein, wogonin, oroxylin A, chrysin, scutellarin, oroxylin A-7-O-glucuronide, apigenin and apigenin-7-glucuronide) in crude and wine-processed R. scutellariae. The quantitative determination was conducted by UHPLC. Optimal separation was achieved by gradient elution with mobile phase consisting of 0.01% aqueous formic acid and methanol on a Waters ACQUITY UHPLC BEH C18 column. Detection wavelength was set at 275 nm. Method validation was accomplished with linearity, precision and recovery tests. All calibration curves showed good linearity (R(2) > 0.9993). The limit of detection and limit of quantification of these compounds were from 0.08 to 0.24 µg/mL and from 0.23 to 0.76 µg/mL, respectively. The average recoveries of these compounds were from 96.95 to 109.51% with relative standard deviation (RSD) values from 2.14 to 3.26% for crude R. scutellariae, while from 94.73 to 108.38% with RSD values from 1.83 to 3.47% for wine-processed R. scutellariae. The developed method can be applied to the intrinsic quality control of crude and wine-processed R. scutellariae.